Are Combinations the Answer in Metastatic RCC?

Robert J. Motzer, MD, provides perspective on recent data from the phase 3 CLEAR trial (Study 307)/KEYNOTE-581 for advanced renal cell carcinoma.

Related Videos
Chandler H. Park, MD, an expert on renal cell carcinoma
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Related Content